BACKGROUND: Hyperinsulinemia and the metabolic syndrome are both risk factors for breast cancer. It is not clear if diabetes is associated with the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. METHODS: The authors reviewed the medical histories of 6052 women with a BRCA1 or BRCA2 mutation, half of whom had been diagnosed with breast cancer. They estimated the odds ratio for breast cancer, given a self-report of diabetes. They then estimated the hazard ratio for a new diagnosis of diabetes associated with a history of breast cancer. RESULTS: There was no excess of diabetes in the period before the diagnosis of breast cancer, compared with controls with no diagnosis of breast cancer. The risk of diabetes was doubled among BRCA carriers in the 15-year period after the diagnosis of breast cancer (relative risk, 2.0; 95% confidence interval [CI], 1.4-2.8; P = .0001), compared with carriers without cancer. The risk was particularly high for women with a body mass index (BMI) >25.0 kg/m(2) (odds ratio, 5.8; 95% CI, 4.0-8.6; P = .0001). CONCLUSIONS: After a diagnosis of breast cancer, women with a BRCA1 or BRCA2 mutation face a 2-fold increase in the risk of diabetes, which is exacerbated by a high BMI.
BACKGROUND:Hyperinsulinemia and the metabolic syndrome are both risk factors for breast cancer. It is not clear if diabetes is associated with the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. METHODS: The authors reviewed the medical histories of 6052 women with a BRCA1 or BRCA2 mutation, half of whom had been diagnosed with breast cancer. They estimated the odds ratio for breast cancer, given a self-report of diabetes. They then estimated the hazard ratio for a new diagnosis of diabetes associated with a history of breast cancer. RESULTS: There was no excess of diabetes in the period before the diagnosis of breast cancer, compared with controls with no diagnosis of breast cancer. The risk of diabetes was doubled among BRCA carriers in the 15-year period after the diagnosis of breast cancer (relative risk, 2.0; 95% confidence interval [CI], 1.4-2.8; P = .0001), compared with carriers without cancer. The risk was particularly high for women with a body mass index (BMI) >25.0 kg/m(2) (odds ratio, 5.8; 95% CI, 4.0-8.6; P = .0001). CONCLUSIONS: After a diagnosis of breast cancer, women with a BRCA1 or BRCA2 mutation face a 2-fold increase in the risk of diabetes, which is exacerbated by a high BMI.
Authors: J A Baron; E Weiderpass; P A Newcomb; M Stampfer; L Titus-Ernstoff; K M Egan; E R Greenberg Journal: Cancer Causes Control Date: 2001-12 Impact factor: 2.506
Authors: A Antoniou; P D P Pharoah; S Narod; H A Risch; J E Eyfjord; J L Hopper; N Loman; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; O-P Kallioniemi; D Thompson; C Evans; J Peto; F Lalloo; D G Evans; D F Easton Journal: Am J Hum Genet Date: 2003-04-03 Impact factor: 11.025
Authors: Theresa H M Keegan; Roger L Milne; Irene L Andrulis; Ellen T Chang; Meera Sangaramoorthy; Kelly-Anne Phillips; Graham G Giles; Pamela J Goodwin; Carmel Apicella; John L Hopper; Alice S Whittemore; Esther M John Journal: Breast Cancer Res Treat Date: 2010-02-07 Impact factor: 4.872
Authors: Alka M Kanaya; David Herrington; Eric Vittinghoff; Feng Lin; Deborah Grady; Vera Bittner; Jane A Cauley; Elizabeth Barrett-Connor Journal: Ann Intern Med Date: 2003-01-07 Impact factor: 25.391
Authors: Kathleen M Sturgeon; Lorraine T Dean; Mariane Heroux; Jessica Kane; Toni Bauer; Erica Palmer; Jin Long; Shannon Lynch; Linda Jacobs; David B Sarwer; Mary B Leonard; Kathryn Schmitz Journal: J Cancer Surviv Date: 2016-11-21 Impact factor: 4.442
Authors: Krishna K Singh; Praphulla C Shukla; Adrian Quan; Jean-François Desjardins; Fina Lovren; Yi Pan; Vinay Garg; Sumandeep Gosal; Ankit Garg; Paul E Szmitko; Michael D Schneider; Thomas G Parker; William L Stanford; Howard Leong-Poi; Hwee Teoh; Mohammed Al-Omran; Subodh Verma Journal: J Biol Chem Date: 2011-12-08 Impact factor: 5.157
Authors: Minghui Cao; Roi Isaac; Wei Yan; Xianhui Ruan; Li Jiang; Yuhao Wan; Jessica Wang; Emily Wang; Christine Caron; Steven Neben; Denis Drygin; Donald P Pizzo; Xiwei Wu; Xuxiang Liu; Andrew R Chin; Miranda Y Fong; Ziting Gao; Kaizhu Guo; Oluwole Fadare; Richard B Schwab; Yuan Yuan; Susan E Yost; Joanne Mortimer; Wenwan Zhong; Wei Ying; Jack D Bui; Dorothy D Sears; Jerrold M Olefsky; Shizhen Emily Wang Journal: Nat Cell Biol Date: 2022-05-30 Impact factor: 28.213
Authors: Praphulla C Shukla; Krishna K Singh; Adrian Quan; Mohammed Al-Omran; Hwee Teoh; Fina Lovren; Liu Cao; Ilsa I Rovira; Yi Pan; Christine Brezden-Masley; Bobby Yanagawa; Aanika Gupta; Chu-Xia Deng; John G Coles; Howard Leong-Poi; William L Stanford; Thomas G Parker; Michael D Schneider; Toren Finkel; Subodh Verma Journal: Nat Commun Date: 2011-12-20 Impact factor: 14.919